Insys Therapeutics, Inc.
Case Number:
1:19-bk-11292
Court:
Nature of Suit:
Firms
- Hutchison & Steffen
- Rosner Law Group LLC
- Consovoy McCarthy
- Ferry Joseph
- Klehr Harrison
- Blank Rome
- Duane Morris
- Potter Anderson
- Patterson Belknap
- Holland & Knight
- Faegre Drinker
- Womble Bond
- Pachulski Stang
- Stoel Rives
- Richards Layton
- Sullivan Hazeltine
- Cole Schotz
- ASK LLP
- Landis Rath
- Chipman Brown
- Theodora Oringher
- Chamberlain Hrdlicka
- Pillsbury Winthrop
- May Potenza
- Halperin Battaglia
- Connolly Gallagher
- Buchanan Ingersoll
- Gilbert LLP
- McDermott Will & Emery
- Morris Nichols
- Berger Mcdermott
- Skadden Arps
- Whiteford Taylor
- Shipman & Goodwin
- Bielli & Klauder
- Benesch
- Hughes Hubbard
- Montgomery McCracken
- McCarter & English
- Reid Collins
- Akin Gump
- Robins Kaplan
- Sills Cummis
- Morgan & Morgan
- Hogan McDaniel
- Brown Rudnick
- Eckert Seamans
- Chiesa Shahinian
- Barrett Law Group
- Stevens & Lee
- Bonville & Howard
- Hagens Berman
- Wagstaff & Cartmell
- Weil Gotshal
- Keller Postman
- Law Firm of Russell R. Johnson III
- Howard & Howard
- Lowenstein Sandler
- Wilson Sonsini
- Seward & Kissel
- Young Conaway
- Cross & Simon
- Orlans PC
- Mayer Brown
Companies
- McKesson Corp.
- Johnson & Johnson
- Iron Mountain Inc.
- Covance Inc.
- Pioneer Telephone Cooperative Inc.
- H.D. Smith LLC
- Ernst & Young LLP
- The Children's Hospital of Philadelphia
- Ironshore Inc.
- The Cigna Group
- FTI Consulting Inc.
- Receptor Life Sciences
- Lazard Ltd.
- Cencora Inc.
- Toyota Motor Corp.
- Bessemer Group Inc.
- Cardinal Health Inc.
- Salt River Project
Government Agencies
- Missouri Department of Revenue
- Texas Comptroller of Public Accounts
- Pennsylvania Department of Human Services
- State of Nevada
- State of Indiana
- State of Michigan
- California Department of Health Care Services
- State of Maryland
- Commonwealth of Kentucky
- New York State Department of Health
Sectors & Industries:
-
June 19, 2019
McKesson Lands Seat On Insys Creditors Committee
Drug distributor McKesson, which has also drawn accusations it helped fuel the nation's opioid crisis, was among those named Wednesday to the official committee of unsecured creditors in Insys Therapeutics Inc.'s Chapter 11, along with individuals who have filed opioid-related suits and health industry representatives.
-
June 17, 2019
Insys Hit With Nationwide Opioid Class Claim In Ch. 11
Bankrupt Insys Therapeutics was hit Monday with a motion seeking recognition of a proposed nationwide class of privately insured consumers, who say the "scourge of opioid abuse" unleashed by the opioid maker jacked up their premiums.
- ← Previous
- 1
- 2
- 3
- 4
- Next →